Qureator
PrivateLast Round
Seed Round
Mar 6, 2026
Est. Valuation
$29.1M
Total Funding Raised
$22M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Qureator is a biotechnology company that provides an AI-powered human biology platform, featuring microphysiological systems, to revolutionize drug discovery and development for complex diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Biotech Equipment, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Qureator Comparables
Compare Qureator with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| NETRI | 86% | |
| Hesperos Inc. | 85% | |
| BiomimX | 84% |
Qureator Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | Mar 6, 2026 | ||||
| Series A | Jun 1, 2022 | ||||
| Series A | Jan 20, 2021 | ||||
| Accelerator | Jun 26, 2019 |
Key People
Founding team and executive leadership
Qureator Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| DA Value Investment | Series A |
| Winvest Venture Capital | Series A |
| Mint Venture Partners | Series A |
| HG Initiative | Series A |
| HG Initiative | Series A |
| SparkLabs Korea | Accelerator, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 31, 2026
Open roles increased to 6, 24% of headcount.
- Aug 22, 2026
Monthly visitors grew 617% MoM, reaching 4.4K.
Qureator Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Qureator's valuation, stock price, and market status.
Is Qureator a public or private company?
Qureator is a private company.
What is the current stock price of Qureator?
Qureator is a private company with no public stock price. No recent secondary market data is available.
How much is Qureator worth (valuation)?
Qureator's valuation is estimated at $29.1M based on funding round data.
Can I buy Qureator stock?
Qureator shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Qureator's last funding round?
Qureator's most recent funding round was Seed Round on January 20, 2021.
Who are the main investors in Qureator?
Key investors in Qureator include HG Initiative.
Will Qureator IPO soon?
No public IPO plans have been announced for Qureator.
How can I track Qureator secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Qureator's secondary market activity and sign up for updates.